The spend in the Biotechnology industry will be 3.44 Trillion dollars by the year 2030. This spend is based upon explosive growth in one of the hottest sectors of the market, Biotechnology. Scientists, Biologists and Chemists need greater access to information and data. This need for more imminent access to data is driven by innovative disruptive technology firms. When you combine AI, ML and Robotics to automate processes you improve accuracy, eliminate errors and reduce labor costs. In addition, these technologies are providing the ability to access their data immediately, saving time and resulting in more timely decision making, accelerated drug discoveries and expedited treatments. The end result is faster treatments and cures for diseases. We are experiencing the beginning of the convergence between Science and Technology. The future is now!!


Tags
Technology, SaaS, SER